Suraksha Card - Diabetes

For an effective diabetes management you need

Suraksha Card - Diabetes

  • Hemoglobin AIC(HbAIC) test every four months with blood sample collected right at home in 600+ locations in India
  • Preventive Health Checkup consisting of 60+ Laboratory Tests based on blood samples
  • Unlimited 24/7 doctor consultations with DesiMD doctors (Video/ Tele Consultations/ Online queries)
  • Free Video/ Tele consultation (20 mins) for a health review by DesiMD doctor upon enrollment
  • Monthly follow-up by DesiMD doctor reviewing members health
  • Access to electronic medical records online
  • Help with booking an appointment with specialist for a second/ expert opinion
  • Applicable to only one member
  • Validity: 12 Months
  • Latest health updates on a regular basis

A bouquet of services with Suraksha Card-Diabetes


Suraksha Card -
Diabetes

subscribe
  • Applicable to only 1 member
  • Rs. 3500.00
+

Ophthalmologist Consultation

subscribe
  • Two consultation per year
  • Rs. 300.00
+

Diabetologist Consultation

subscribe
  • Three consultations per year
  • Rs. 1200.00
+

Dietician
Consultation

subscribe
  • Two consultations per year
  • Rs. 600.00
+

Self Monitoring
Blood Glucose Meter

subscribe
  • ACCU-Chek® Active Glucose Monitor
  • ACCU-Chek® Active Test Strips – 100 Nos
  • ACCU-Chek® Active Lancets – 100 Nos
  • Will be couriered in 7 business working days
  • Rs. 3400.00


Price : Rs.9000 / $149

    

Apply DIAB5 Coupon Code to get 5% Discount

Enter Image Text

Significance of Hemoglobin A1C (HbA1C) Test

  • A1C reflects average glycemia (sugar levels) for the last 3 months and has strong predictive value for diabetes complications. A1C testing should be performed routinely in all patients with diabetes at initial assessment and as part of continuing care.
  • Recommendations A1C Testing
    • Perform the A1C test at least two times a year in patients who are meeting treatment goals (and who have stable glycemic control)
    • Perform the A1C test quarterly in patients whose therapy has changed or who are not meeting glycemic goals
    • Point-of-care testing for A1C provides the opportunity for more timely treatment changes

References:
American Diabetes Association. Diabetes Care Volume 39, Supplement 1, January 2016. Available at: http://care.diabetesjournals.org/site/misc/2016-Standards-of-Care.pdf

Benefits of Self-Monitoring of Blood Glucose (SMBG)

  • Major clinical trials of insulin-treated patients have included SMBG as part of the multifactorial interventions to demonstrate the benefit of intensive glycemic control on diabetes complications.
  • SMBG allows patients to evaluate their individual response to therapy and assess whether glycemic targets are being achieved. Integrating SMBG results into diabetes management can be a useful tool for guiding medical nutrition therapy and physical activity, preventing hypoglycemia, and adjusting medications (particularly prandial insulin doses).
  • SMBG is thus an integral component of effective therapy
  • Among patients with Type 1 Diabetes, there is a correlation between greater SMBG frequency and lower A1C. The patient’s specific needs and goals should dictate SMBG frequency and timing.
  • Among patients with Type 2 Diabetes also, appropriate use of structured SMBG significantly improves glycemic control and facilitates more timely/aggressive treatment changes without affecting the general well-being of the person
References:
  • The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977–986
  • Miller KM, Beck RW, Bergenstal RM, et al.; T1D Exchange Clinic Network. Evidence of a strong association between frequency of self-monitoring of blood glucose and hemoglobin A1c levels in T1D Exchange clinic registry participants. Diabetes Care 2013;36:2009–2014
  • Polonsky WH, Fisher L, Schikman CH, et al. Structured self-monitoring of blood glucose significantly reduces A1C levels in poorly controlled, noninsulin-treated type 2 diabetes: results from the Structured Testing Program study. Diabetes Care 2011;34:262–267

Recommended guidelines for prevention and management of most common diabetes complications in diabetic patients:

  • Cardiovascular risk factors should be systematically assessed at least annually. These risk factors include dyslipidemia, hypertension, smoking, a family history of premature coronary disease, and the presence of albuminuria.
  • Patients with type 1 or 2 diabetes should have an initial dilated and comprehensive eye examination done by an ophthalmologist or optometrist at the time of the diagnosis of diabetes. If any level of diabetic retinopathy is present, subsequent dilated retinal examinations should be repeated annually, else, examination should be done once in 2 years
  • At least once a year, urinary albumin(e.g., spot urinary albumin–to– creatinine ratio) and estimated glomerular filtration rate must be assessed in patients with type 1 diabetes with duration of greater than 5 years, in all patients with type 2 diabetes, and in all patients with comorbid hypertension. Diabetic kidney disease, or kidney disease attributed to diabetes, occurs in 20–40% of patients with diabetes and is the leading cause of end-stage renal disease (ESRD).
  • All patients should be assessed for diabetic peripheral neuropathy starting at diagnosis of type 2 diabetes and 5 years after the diagnosis of type 1 diabetes and at least annually thereafter
  • Perform a comprehensive foot evaluation each year to identify risk factors for ulcers and amputations
References:

American Diabetes Association. Diabetes Care Volume 39, Supplement 1, January 2016. Available at: http://care.diabetesjournals.org/site/misc/2016-Standards-of-Care.pdf